Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Ria Diagnostics — Predicate Candidate Screening
7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
38 daysmedian FDA review time
133 days90th percentile
7clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K855033 | T-3 UPTAKE/RIASSAY | Ria Diagnostics | 1986-01-24 | 38 | 0 |
| K854798 | T-4 RIASSAY | Ria Diagnostics | 1986-01-15 | 44 | 0 |
| K852537 | T-3 RIASSAY | Ria Diagnostics | 1985-08-12 | 59 | 0 |
| K810296 | DIGOXIN RIA ASSAY | Ria Diagnostics | 1981-02-19 | 15 | 0 |
| K801691 | TSH RIASSAY | Ria Diagnostics | 1980-08-27 | 35 | 0 |
| K792062 | THEOPHYLLINE RIASSAY | Ria Diagnostics | 1980-02-25 | 133 | 0 |
| K780012 | ANTITHROMBIN III RIA | Ria Diagnostics | 1978-01-20 | 17 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda